Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Korean researchers present novel 3-isoxazolylvinylcephalosporins

Oct. 3, 1997

R.W. Johnson identifies TCS inhibitor with potent antibacterial activity

Oct. 3, 1997

Microcide identifies cephalosporin with excellent Gram-positive activity

Oct. 3, 1997

Novel antibacterial agents that inhibit bacterial two-component systems

Oct. 3, 1997

Wakunaga prepares acidic fluoroquinolone

Oct. 3, 1997

Triazole antifungal from Uriach heading for clinic

Oct. 2, 1997

SynPhar selects class C beta-lactamase inhibitor as development candidate

Oct. 2, 1997

T-3811: a new des-F(6)-quinolone from Toyama presented at ICAAC

Oct. 2, 1997

Wakunaga develops new oral fluoroquinolones

Oct. 2, 1997

Nyotran study results described at ICAAC

Oct. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...